EdU incorporation assays further suggested that LINC01016 overexpression enhanced proliferation, whereas LINC01016 knockdown dramatically inhibited the growth capabilities of BC cells (Fig. 3C, D and Supplementary Fig. 3B). This evidence concerns the gene LINC01016 and breast cancer.